Abstract
Hepatocyte growth factor/scatter factor (HGF/SF) is secreted by mesenchymal cells and elicits proliferation, motility, differentiation, and morphogenesis of epithelia and other cells. These effects are mediated by binding to MET, a receptor tyrosine kinase. Genetically engineered mice lacking HGF/SF die in utero due to a failure of placental and hepatocyte differentiation, but little information exists regarding the expression of this signaling system in human development. Using reverse transcriptase-polymerase chain reaction, Western blots, and immunohistochemistry, we report that HGF/SF and MET are expressed during critical early periods of human organogenesis from 6 to 13 wk of gestation. Organs that expressed both genes included liver, metanephric kidney, intestine, and lung, each of which develop by inductive interactions between mesenchyme and epithelia. Of all organs studied, the placenta contained the highest levels of HGF/SF protein, and MET was detected in trophoblastic cells of chorionic villi as early as the 5th wk of gestation. Finally, examination of a human multicystic dysplastic kidney demonstrated that malformed, hyperproliferative tubules expressed MET, whereas HGF/SF protein was immunolocalized to the same epithelia and also to the surrounding undifferentiated cells. Hence HGF/SF might be an important growth factor in normal human embryogenesis and may additionally play a role in human organ malformations.
Similar content being viewed by others
Main
HGF/SF is a disulfide-linked heterodimeric heparin-binding molecule secreted by embryonic mesenchymal cells and adult derivatives such as fibroblasts(1–3). It has roles in both normal embryonic development, oncogenesis, and in regeneration of adult organs(4). These actions are mediated by MET, a membrane-bound receptor tyrosine kinase which undergoes autophosphorylation upon binding HGF/SF and transduces growth signals into the cell(5, 6). In mice MET is expressed by diverse epithelia(1, 7, 8) and also by chondrocytes(9), endothelia(10), hematopoietic precursors(11), neurons(12), renal mesenchymal(7) and mesangial cells(13), and myogenic precursors(14).
Based on cell and organ culture experiments(1, 7, 15–17), as well as expression patterns of HGF/SF and MET in mice and rats(7, 18, 19), it was postulated that HGF/SF elicits embryonic epithelial growth and morphogenesis by paracrine or even autocrine signaling systems. Indeed, mice with homozygous null-mutations for either HGF/SF or met have impaired growth and die in utero due to perturbed trophoblast and hepatocyte differentiation(14, 20, 21).
Little is known, however, about the HGF/SF-MET axis in early human development. We now demonstrate that the ligand and receptor are widely expressed during critical early periods of human organogenesis between 6 and 13 wk after fertilization. In addition, the expression pattern of HGF/SF and MET by multicystic dysplastic kidney cells suggests a role for the ligand and receptor in a case of abnormal epithelial growth in a human organ malformation(22–24).
METHODS
Sources of tissues. Human fetuses were provided by the Medical Research Council-funded Human Embryo Bank at the Institute of Child Health, from collections made under local research ethical committee permission. Thirteen normal fetuses were collected from chemically induced and surgical terminations performed 5-13 wk after fertilization as described previously(25). Gestational age was determined by standard criteria from external morphology(26). All chemicals were supplied by Sigma Chemical Co. (Poole, Dorset, UK) unless otherwise stated. Embryos for histology were fixed in 4% paraformaldehyde in PBS (pH 7.0) overnight, embedded in paraffin wax, and sectioned at 5 μm. Other embryos were dissected in ice-cold Liebowitz-15 media (Life Technologies, Inc., Gaithersburg, MD), and organs were snap-frozen for biochemical analysis. A postnatal human dysplastic kidney harvested at nephrectomy was fixed, embedded in paraffin wax, and sectioned exactly as we have previously described(23, 24).
RT-PCR. RT-PCR was performed at each stage from two embryos. It should be emphasized that this RT-PCR methodology is sensitive and specific, but it is not quantitative. RNA was extracted from fetal organs using TRI-REAGENT (Molecular Research Center, Cincinnati, OH). Next, 300 ng of RNA were treated with deoxyribonuclease I to degrade contaminating DNA and subjected to RT-PCR as described elsewhere(7). Primers were: MET sense primer 5′-ACA GCG CGC CGT GAT GAA TAT CGA-3′, corresponding to nucleotides 1230-1254 of human MET cDNA (cDNA)(27); MET antisense 5′-GCA GCC CAA GCC ATT CAA TGG GAT-3′, corresponding to nucleotides 1536-1560 of human MET cDNA; HGF/SF sense 5′-TCC ATG ATA CCA CAC GAA CAC AGC-3′ corresponding to nucleotides 458-482 of human HGF/SF cDNA(28); and HGF/SF antisense 5′-TGC ACA GTA CTC CCA GCG GGT GTG-3′ corresponding to nucleotides 828-852 of human HGF/SF cDNA. Primers forβ-actin, a housekeeping gene, were obtained from Clontech (Palo Alto, CA). RNA was reverse transcribed and subjected to PCR as described elsewhere(7). The PCR machine (Quatro TC-40) was programmed for 30 cycles of 94 °C for 1 min; then 65 °C for 1 min for MET andβ-actin or 67 °C for 1 min for HGF/SF; then 72 °C for 1 min. Seven microliters of reaction products were electrophoresed through a 1% agarose gel with ethidium bromide. These protocols resulted in the following products: 330 bp for MET, 394 bp for HGF/SF, and 838 bp for β-actin. RT-PCR products were subcloned in Bluescript XL1 Blue (Stratagene, La Jolla, CA) and sequenced to confirm their identities (data not shown).
Immunohistochemistry. Sections were dewaxed through HistoClear(National Diagnostics, Atlanta, GA) followed by rehydration in 30-100% alcohol. After washing in PBS (pH 7.4) for 5 min, fetal sections were microwaved for 8 min. After cooling and washing in PBS, they were incubated in 3% hydrogen peroxide for 15 min to quench endogenous peroxidase activity. Nonspecific binding was blocked with 10% vol/vol FCS in PBS, and primary antibodies were applied for 1 h at 37 °C. Anti-HGF/SF raised in sheep against whole human factor (from E. Gherardi, ICRF, Cambridge, UK) and anti-MET rabbit antiserum raised against the carboxy terminus of human MET(Santa Cruz Biotechnology, Santa Cruz, CA) were used as described previously(13). Preliminary experiments showed no signal upon either omitting primary antibodies or preincubation at room temperature for 2 h with recombinant HGF/SF (a gift from E. Gherardi, ICRF, Cambridge, UK) or MET peptide (Santa Cruz Biotechnology); both were used at 10 times the concentration of primary antibodies(13). Primary antibodies were detected using a streptavidin biotin peroxidase system (ABC Kit, DAKO, Carpinteria, CA) followed by diaminobenzidine. Sections were counterstained with hematoxylin and mounted in dextropropoxyphene (BDH, Poole, UK) and examined on a Zeiss Axiophot microscope (Carl Zeiss, 7082 Oberkochen, Germany). Sections of human dysplastic kidney were treated similarly except that primary antibodies were detected with FITC-conjugated second antibodies as described previously(13). Slides were mounted in Citifluor (Chemical Labs, Canterbury, UK) and were examined under fluorescence(wavelength 488 nm) on a Leica confocal laser scanning microscope(Aristoplan-Leica, Heidelberg, Germany) as described previously(13).
Western blot. Organs were lysed in ice-cold radioimmune precipitation assay buffer (PBS with 1% Nonidet P-40, 10 mM sodium deoxycholate, 0.1% SDS, 1 mM phenylmethylsulfonyl fluoride, 200 nM aprotinin, and 1 mM sodium orthovanadate). Protein was measured by the BCA protein assay as described by the manufacturer (Pierce, UK), and 10 μg were used directly for HGF/SF Western blots or was first immunoprecipitated essentially as described previously(13) before HGF/SF or MET blots. Briefly, lysate was precleared with normal rabbit IgG and protein A-agarose(Santa Cruz Biotechnology). After centrifugation, the supernatant was reacted with anti-MET or anti-HGF/SF antibodies for 1 h at 4 °C, followed by addition of 20 μL of protein A-agarose and incubation overnight at 4°C. Proteins were resuspended and heat denatured at 100 °C for 5 min, separated by electrophoresis in a 0.2 M SDS-polyacryl-amide gel(29), and transferred onto nitrocellulose (Hybond-C Extra; Amersham, UK)(30). Membranes were incubated in blocking solution (5% nonfat milk in Tris-buffered saline) at 4 °C overnight and reacted with primary antibodies which were detected with horseradish peroxidase-conjugated second antibodies and enhanced chemiluminescence reagent (ECL, Amersham, UK). Proteins were sized with Rainbow markers (Amersham, UK).
RESULTS
HGF/SF and MET fetal mRNA. As assessed by RT-PCR, we found both genes expressed in the following organs between 6 and 13 wk of gestation: metanephric kidneys, adrenal glands, liver, lung, brain, stomach, intestines, heart, and placenta. We also found mRNA for HGF/SF and MET in mesonephric kidneys between 6 and 8 wk; these organs involute later in gestation. We also detected mRNA for both genes in skin and eye at 10 wk and in pancreas at 13 wk. In general there was coexpression of ligand and receptor mRNA, with the exception of spinal cord at 6 wk when only MET was detected. These results are summarized in Table 1, and typical RT-PCR products are shown in Figure 1 with each stage representing consistent data from two embryos.
Overview of HGF/SF and MET fetal protein analysis. Many organs showed specific immunohistochemical signals for MET, as described below. In contrast, the placenta showed an intense immunohistochemical signal for HGF/SF, whereas no consistent specific staining pattern was observed in other organs. Because most organs expressed HGF/SF mRNA as assessed by the sensitive RT-PCR technique, we speculated that levels of HGF/SF protein were relatively low in nonplacental tissues. To investigate this further, equal amounts of protein from different organs (liver, lung, hands, feet, metanephric kidney, mesonephros, placenta, and gut) from a 10-wk embryo were studied by Western blots (Fig. 2). HGF/SF protein was detected in all specimens, but the signal was highest in the placenta.
Placenta. Chorionic villi are the fetal component of the placenta, and before 20 wk the placental barrier consists of a syncytiotrophoblast enveloping the cytotrophoblast layer, which itself encloses a core of connective tissue, Hofbauer phagocytic cells, and endothelia(26). Chorionic villi of a 5-wk human fetus are shown in Figure 3. The multinucleate syncytiotrophoblast and mononuclear cells of the cytotrophoblast stained intensely for HGF/SF protein. In contrast, MET immunostaining was confined to the cytotrophoblast. In addition, endothelia within the villus stained for both HGF/SF and MET, whereas a subset of connective tissue or phagocytic cells in the core of the villus stained for HGF/SF protein. Villi from later ages showed similar expression patterns. Finally, endothelia in the maternal component of the placenta, the decidua basalis, were positive for MET but not HGF/SF (data not shown).
Liver. The liver arises as a ventral bud of the foregut endoderm in the 4th wk after fertilization and gives rise to the hepatocytes and biliary ducts. These epithelia interact with part of the splanchnic mesoderm called the septum transversum, which will contribute to the diaphragm and hematopoietic and Kupffer cells(26). We were unable to detect specific signals for either HGF/SF or MET using immunohistochemistry in the human liver between 6 and 13 wk, despite the presence of mRNA for both genes (Fig. 1 and Table 1). Therefore, we performed Western blots after immunoprecipitation of liver protein; appropriate bands for both HGF/SF and MET (Fig. 4) were detected at 10 wk of gestation and at earlier and later stages (data not shown).
Kidney. The metanephroi are direct precursors of the adult kidneys(26). They are first detected at 6 wk when the ureteric bud interacts with intermediate mesoderm called renal mesenchyme; the first glomeruli form by 9 wk. At this stage an intense signal for MET was detected in ureteric bud branches (Fig. 5,A and D) and in immature nephrons, the S-shaped bodies (Fig. 5A). In these epithelia, immunostaining was localized to the basal plasma membrane. A lower intensity of MET staining was observed in condensates and vesicles, which are cells undergoing a conversion from a mesenchymal to epithelial phenotype (Fig. 5A). In fetal glomeruli, positive MET immunostaining was found in Bowman's capsule and in endothelial and mesangial cells situated in the core of the glomerulus (Fig. 5C).
Other sites of MET expression. The lung bud develops at 3-4 wk and subsequently branches in the surrounding splanchnic mesenchyme. Between 5 and 13 wk, the lung is pseudoglandular, resembling an exocrine gland(26). Figure 6A shows a 13-wk organ where MET immunostaining was observed in the apical epithelial domain. Cartilaginous plates develop from the splanchnic mesenchyme around the tracheal and large bronchial epithelia; here we observed MET staining in chondrocytes (Fig. 6C). MET immunostaining was detected in the basal domain of fetal intestinal epithelia (Fig. 6E) and in perineural tissue around dorsal spinal nerves (Fig. 6G). Endothelia stained for MET in many organs including placenta (Fig. 3F), kidney (Fig. 5C), and heart (not shown). MET immunostaining was also detected in cartilage of the appendicular skeletal (fetal digits) and vertebrae of the axial skeleton (data not shown), both of which undergo endochondral ossification.
HGF/SF and MET in a kidney malformation. Multicystic dysplastic kidneys contain dysplastic tubules which terminate in cysts; these structures are considered to be aberrant branches of the ureteric bud(22). HGF/SF immunolocalized to stromal and mesenchymal cells surrounding dysplastic tubules, and also to dysplastic epithelia themselves (Fig. 7A). HGF/SF immunoreactivity was also noted on the epithelial surface of cysts and in amorphous material in cyst lumens (Fig. 7C). MET protein was detected in the apical, lateral, and basal membrane domains of dysplastic tubule and cystic epithelia (Fig. 7,C and D). Stromal and undifferentiated cells did not express MET, as assessed by this technique.
DISCUSSION
Our study shows that HGF/SF and MET mRNAs are widely expressed in the human embryo during early organogenesis from 6 wk of gestation when differentiation often proceeds by mesenchymal/epithelial interactions(26). Hence HGF/SF may be an important growth factor in early human embryogenesis. These results extend observations from a study which used Northern blots to detect HGF/SF and MET mRNA and in situ hybridization to localize HGF/SF transcripts in fetuses between 9 and 17 wk(31). That report showed HGF/SF and MET mRNAs were expressed by a similar range of organs as we have studied. Some human organs such as the metanephros, however, are relatively differentiated by 9 wk, and therefore the earlier time-frame of our study may be more relevant to early organogenesis(26). Furthermore, Wang et al.(31) did not assess the localization of MET protein or measure HGF/SF protein.
We found organs with a very specific pattern of MET immunostaining. In fetal kidney, gut, and lung the expression of the HGF/SF receptor was marked in epithelia, a pattern consistent with a studies in embryonic mice(18). MET protein was located in basal plasma membranes of metanephric and gut epithelia, where it would be well placed to receive a paracrine signal from HGF/SF secreted by adjacent mesenchyme(18). In fact, functional animal experiments implicate mesenchyme-derived HGF/SF in epithelial growth during nephrogenesis(7) and in the adult gut(8). In contrast, we found that MET immunostaining was localized apically in the branching epithelia of the developing lung, in which case the ligand would need to access the luminal surface. HGF/SF null-mutant mice have abnormal liver development(20), and HGF/SF stimulates DNA synthesis in fetal rat hepatocytes(19). Our study confirms that MET mRNA and protein were present in very early human hepatogenesis, although we were unable to immunolocalize the protein.
We found that MET expression was not confined to epithelial cells. Fetal chondrocytes in bronchi as well as in axial and appendicular skeleton expressed MET, a finding consistent with an animal study in which HGF/SF stimulated proliferation and proteoglycan synthesis in adult chondrocytes(9). Similarly, we found low levels of MET in renal mesenchymal condensates and fibromuscular mesangial cells, consistent with our previous studies of developing mice(7, 13). Human fetal endothelia also expressed MET, and there is animal evidence that HGF/SF can act as an angiogenic factor(10).
We found that many developing tissues expressed HGF/SF mRNA as assessed by RT-PCR. However, it was not possible to obtain a specific immunohistochemical signal for HGF/SF in these tissues, with the exception of chorionic villi. HGF/SF protein was detected by Western blot in a variety of fetal tissues with the strongest signal in the placenta. We therefore speculate that levels of HGF/SF protein are relatively low in nonplacental tissues. If secreted HGF/SF were to have the ability to diffuse widely, then this would provide another explanation for our failure to detect specific HGF/SF immunohistochemical signals in most organs. Indeed, HGF/SF circulates in the human fetal plasma, and levels increase in late gestation(32). The sources of fetal plasma HGF/SF are undefined but might include placenta, the fetus itself, or transmission from maternal circulation.
Our Western blot data suggest that the placenta is a rich source of HGF/SF protein, and this organ is known to be a rich source of other growth factors(33). We found that both the syncytio- and cytotrophoblast contain high levels of HGF/SF protein, confirming a recent study of Wolf et al.(33). Another report, using in situ hybridization, demonstrated that the syncytiotrophoblast expresses HGF/SF mRNA(31). Of note, HGF/SF stimulates the proliferation of cytotrophoblasts in vitro(34), consistent with our observation that MET immunostaining was prominent in these cells in vivo. Although classical studies have emphasized that HGF/SF expression is generally a property of mesenchymal cells(1), Wang et al.(31) found that epithelia of the human fetal gut, tongue, and skin expressed this gene using in situ hybridization. Although these data appear to contradict expression patterns of HGF/SF in mouse development(18), if embryonic HGF/SF is indeed made by some epithelial as well as mesenchymal cells, there would be scope for autocrine as well as paracrine modes of action. We have tried to perform in situ hybridization for HGF/SF in human embryos; thus far we have yet to obtain a convincing signal from any tissue apart from placenta (M.K.-J. and A.S.W., unpublished observations).
Recently, a human cranial malformation (Crouzon syndrome) was linked to mutation of the fibroblast growth factor receptor 2 gene(35). Like MET, this is a receptor tyrosine kinase. Human fetal deaths or organ malformations have yet to be linked to mutations of either HGF/SF or MET, both located on chromosome 7. However, we considered it instructive to examine the expression of this signaling system in the multicystic dysplastic kidney, an example of abnormal epithelial/mesenchymal interaction. The etiology of these malformations is unknown(22), but they contain tubules and cysts, which are abnormal collecting ducts, surrounded by stromal cells, considered to be mesenchymal cells that fail to form nephrons(22–24). We previously demonstrated that dysplastic epithelia express PAX2, a potentially oncogenic transcription factor, and maintain a high rate of proliferation postnatally(24). Other data from our laboratory, using mouse metanephros as a model, showed that renal mesenchyme secretes bioactive HGF/SF; moreover, blocking antisera to HGF/SF prevented the growth of primitive collecting ducts in organ culture(7). Another study, using similar methodologies, concluded that HGF/SF enhanced elongation of ureteric bud branches(36).
Our preliminary observations show that dysplastic renal tubules and cysts express MET, and furthermore, HGF/SF immunolocalizes to dysplastic tubules and surrounding stromal cells (Fig. 7). Another laboratory reported that MET immunostaining was barely detectable in collecting ducts of normal postnatal kidneys(37), and our own unpublished data demonstrate that HGF/SF and MET immunoreactivity is minimal in the mature kidney (A.S.W. and P.J.D.W., personal observations). Therefore, our descriptive observations suggest that HGF/SF may play a role in growth of dysplastic epithelia. Two other studies are of relevance here. Natali et al.(37) found that MET was overexpressed in human renal carcinomas, whereas Horie et al.(38) reported that HGF/SF and MET mRNA were coexpressed in walls of hyperproliferative autosomal dominant polycystic kidney disease cysts; moreover, immunoreactive HGF/SF was detected in cyst lumens. At present we are constructing cell lines from dysplastic kidneys to investigate functional aspects of HGF/SF and MET in vitro. In future it will be interesting to study the expression of HGF/SF and MET in malformations of other human organs.
Abbreviations
- HGF/SF:
-
hepatocyte growth factor/scatter factor
- RT:
-
reverse transcriptase
- PCR:
-
polymerase chain reaction
References
Stoker M, Gherardi E, Perryman M, Gray J 1987 Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239–242
Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S 1989 Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440–443
Gherardi E, Gray J, Stoker M, Perryman M, Furlong R 1989 Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA 86: 5844–5848
Rosen EM, Nigam SK, Goldberg ID 1994 Scatter factor and the c-met receptor: a paradigm for mesenchymal-epithelial interaction. J Cell Biol 127: 1783–1787
Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA 1991 Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802–804
Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos GK 1991 Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10: 2867–78
Woolf AS, Kolatsi-Joannou M, Hardman P, Andermarcher E, Moorby C, Fine LG, Jat PS, Noble MD, Gherardi E 1995 Roles of hepatocyte growth factor/scatter factor (HGF/SF) and Met in early development of the metanephros. J Cell Biol 128: 171–184
Takahashi M, Ota S, Shimada T, Hamada E, Kawabe T, Okudaira T, Matsumura M, Kaneko N, Terano A, Nakamura T, Omata M 1995 Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J Clin Invest 95: 1994–2003
Takebayashi T, Iwamoto M, Jikko M, Matsumura T, Enomoto-Iwamoto M, Myoukai F, Koyama E, Yamaai T, Matsumoto K, Nakamura T, Kurisu K, Noji S 1995 Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes. J Cell Biol 129: 1411–1419
Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM 1993 Scatter factor induces blood vessel formation in vivo. Proc Nat Acad Sci USA 90: 1937–1941
Galimi F, Bagnara GP, Bonsi L, Cottone E, Follenzi A, Simeone A 1994 Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J Cell Biol 127: 1743–1754
Jung W, Castren E, Odenthal M, Vande Woude GF, Ishii T, Dienes H-P, Lindholm D, Shirmacher P 1994 Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 126: 485–494
Kolatsi-Joannou M, Woolf AS, Hardman P, Gordge M, White SJ, Henderson R 1995 The hepatocyte growth factor/scatter factor (HGF/SF) receptor, met, transduces a morphogenetic signal in renal glomerular fibromuscular mesangial cells. J Cell Sci 108: 3703–3714
Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C 1995 Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376: 768–771
Tsarfaty I, Rong S, Resau JH, Rulong S, da Silva PP, Van de Woude GF 1994 The met proto-oncogene mesenchymal to epithelial cell conversion. Science 263: 98–101
Montesano R, Matsumoto K, Nakamura T, Orci L 1991 Identification of fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67: 901–908
Berdichevsky F, Alford D, D'Souza B, Taylor-Papadimitriou J 1994 Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci 107: 3557–3568
Sonnenberg ED, Meyer D, Weidner KM, Birchmeier C 1993 Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 123: 223–235
Defrances MC, Wolf HK, Michalopoulos GK, Zarnegar R 1994 The presence of hepatocyte growth factor in the developing rat. Development 116: 387–395
Schimidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C 1995 Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373: 699–702
Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, Kitamura N 1995 Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373: 702–705
Woolf AS 1995 Clinical impact and biological basis of kidney malformations. Semin Nephrol 15: 361–372
Winyard PJD, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon AR, Woolf AS 1996 Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 49: 135–146
Winyard PJD, Risdon RA, Sams VR, Dressler GR, Woolf AS 1996 The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J Clin Invest 98: 451–459
Duke V, Winyard PJD, Thorogood PV, Soothill P, Bouloux PMG, Woolf AS 1995 KAL, a gene mutated in Kallmann's syndrome, is expressed in the first trimester of human development. Mol Cell Endocrinol 110: 73–79
Larsen WJ 1993 Human Embryology. Churchill Livingstone, New York, pp 7–420
Park M, Dean M, Kaul K, Braun J, Gonda M, Vande Woude GF 1987 Sequence of met proto-oncogene cDNA has features characteristic of tyrosine kinase family of growth factor receptors. Proc Natl Acad Sci USA 84: 6379–6383
Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Gohda E, Daikuhara Y, Kitamura N 1989 Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163: 967–973
Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277: 680–685
Matsudaira P 1987 Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 262: 10035–10038
Wang Y, Selden S, Farnaud S, Calnan D, Hodgson HJF 1994 Hepatocyte growth factor (HGF/SF) is expressed in human epithelial cells during embryonic development; studies by in situ hybridisation and Northern blot analysis. J Anat 185: 543–551
Khan N, Couper J, Goldsworthy J, Aldis J, McPhee A, Couper R 1996 Relationship of hepatocyte growth factor in human umbilical vein serum to gestational age in normal pregnancies. Pediatr Res 39: 386–389
Wolf HK, Zarnegar R, Letailia O, Michalopoulos GK 1991 Hepatocyte growth factor in human placenta and trophoblastic disease. Am J Pathol 138: 1035–1051
Sato S, Sakakura S, Enomoto M, Ichijom M, Matsumoto K, Nakamura T 1995 Hepatocyte growth factor promotes the growth of cytotrophoblasts by a paracrine mechanism. J Biochem 117: 671–676
Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S 1994 Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet 8: 98–101
Davies JA, Lyon M, Gallagher J, Garrod DR 1995 Sulphated proteoglycan is required for collecting duct growth and branching but not nephron formation during kidney development. Development 121: 1507–1517
Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM, Di Renzo MF 1996 Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer 69: 212–217
Horie S, Higashihara E, Nutahara K, Mikami Y, Okubo A, Kano M, Kawabe K 1994 Mediation of renal cyst formation by hepatocyte growth factor. Lancet 344: 789–791
Acknowledgements
The authors thank Ermanno Gherardi (MRC Centre, Cambridge, UK) for HGF/SF antibody and recombinant HGF/SF.
Author information
Authors and Affiliations
Additional information
Supported by the Wellcome Trust (M.K.-J.), the National Kidney Research Fund (A.S.W.), Action Research (P.J.D.W.), and the Medical Research Council(R.M.).
Rights and permissions
About this article
Cite this article
Kolatsi-Joannou, M., Moore, R., Winyard, P. et al. Expression of Hepatocyte Growth Factor/Scatter Factor and Its Receptor, MET, Suggests Roles in Human Embryonic Organogenesis. Pediatr Res 41, 657–665 (1997). https://doi.org/10.1203/00006450-199705000-00010
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199705000-00010
This article is cited by
-
MACC1 — more than metastasis? Facts and predictions about a novel gene
Journal of Molecular Medicine (2010)
-
Expression of p53/hgf/c-met/STAT3 signal in fetuses with neural tube defects
Virchows Archiv (2007)
-
Increased c-Met tyrosine kinase expression in segmental renal dysplasia
Pediatric Nephrology (2003)